Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
14.28
-0.34 (-2.33%)
At close: Nov 21, 2024, 4:00 PM
14.50
+0.22 (1.54%)
After-hours: Nov 21, 2024, 5:56 PM EST
Arcus Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,307 | 1,430 | 1,497 | 2,843 | 1,685 | 463 | |
Market Cap Growth | 4.53% | -4.52% | -47.33% | 68.68% | 263.88% | -3.26% | |
Enterprise Value | 326 | 604 | 568 | 2,367 | 903 | 272 | |
Last Close Price | 14.62 | 19.10 | 20.68 | 40.47 | 25.96 | 10.10 | |
PE Ratio | - | - | - | 57.00 | - | - | |
Forward PE | - | - | - | - | 12.60 | - | |
PS Ratio | 4.78 | 12.22 | 13.37 | 7.42 | 21.61 | 30.88 | |
PB Ratio | 2.37 | 3.09 | 2.28 | 3.38 | 3.36 | 2.83 | |
P/TBV Ratio | 2.47 | 3.09 | 2.28 | 3.38 | 3.36 | 2.83 | |
P/FCF Ratio | - | - | 3.47 | - | 15.61 | - | |
P/OCF Ratio | - | - | 3.42 | - | 15.18 | - | |
EV/Sales Ratio | 1.24 | 5.16 | 5.07 | 6.18 | 11.58 | 18.15 | |
EV/EBITDA Ratio | - | - | - | 40.82 | - | - | |
EV/EBIT Ratio | - | - | - | 43.84 | - | - | |
EV/FCF Ratio | - | - | 1.31 | - | 8.36 | - | |
Debt / Equity Ratio | 0.14 | 0.26 | 0.18 | 0.14 | 0.03 | - | |
Debt / EBITDA Ratio | - | - | - | 1.80 | - | - | |
Debt / FCF Ratio | - | - | 0.28 | - | 0.14 | - | |
Asset Turnover | 0.22 | 0.10 | 0.08 | 0.32 | 0.16 | 0.06 | |
Quick Ratio | 5.16 | 4.35 | 5.45 | 7.51 | 6.00 | 8.31 | |
Current Ratio | 5.24 | 4.52 | 5.53 | 7.60 | 6.05 | 8.49 | |
Return on Equity (ROE) | -49.77% | -54.87% | -35.62% | 7.89% | -36.93% | -42.48% | |
Return on Assets (ROA) | -15.25% | -17.42% | -11.92% | 2.85% | -15.89% | -23.20% | |
Return on Capital (ROIC) | -28.92% | -31.25% | -20.16% | 4.57% | -22.75% | -27.81% | |
Earnings Yield | -20.60% | -21.47% | -17.83% | 1.86% | -7.30% | -18.29% | |
FCF Yield | -12.89% | -23.08% | 28.85% | -9.92% | 6.41% | -16.28% | |
Buyback Yield / Dilution | -17.25% | -2.78% | 2.70% | -35.04% | -25.04% | -26.60% | |
Total Shareholder Return | -17.25% | -2.78% | 2.70% | -35.04% | -25.04% | -26.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.